Spearheading End-to-End LNP Development by Leveraging Novel Lipids, Incorporating Automation & Improving Reliability of LNP Analytics to Accelerate LNPs from Research to Market
The 5th Lipid Nanoparticles Development Summit Europe took place in Berlin at a pivotal moment for the field, as LNPs moved beyond COVID-19 vaccines into broader therapeutic applications, including gene editing, oncology and in vivo cell therapy. The meeting brought together leading biotech, pharma and academic experts to tackle the biggest barriers preventing LNPs from reaching their full clinical potential.
What made this event stand out was its end-to-end focus, covering everything from early design and intracellular delivery, through analytical and CMC strategy, to regulatory alignment and scalable manufacturing. Unlike traditional meetings, it went beyond well-known challenges to spotlight next-generation innovations, including extrahepatic targeting, hybrid nanoparticle systems and strategies for repeat dosing and reduced toxicity.
The summit arrived at a critical time for the industry. As organisations faced increasing scrutiny around safety, delivery precision and commercial viability, there was a growing need to align innovation with real-world application and regulatory expectations. Through expert-led sessions, interactive debates and practical case studies, attendees explored the latest advances and challenges shaping the future of LNP-based therapeutics.
For those serious about advancing LNP-based therapeutics, the summit provided an important forum to gain clarity, challenge assumptions and accelerate progress.
The event was well distributed between research talks, company talks and moments for networking.
Analytical Development Scientist, BSP Pharmaceuticals
Cutting-edge presentations.
Formulation Scientist, Daiichi Sankyo
Explore the Previous Event Guide
- Get a clear, at-a-glance view of the previous agenda, themes and speaker line-up
- Identify the sessions that would have been most relevant to your work and key LNP challenges
- Explore how leading companies were tackling delivery, targeting and scalability
- Discover the interactive sessions, debates and networking opportunities the summit provided
- Easily share with colleagues to align on future attendance and priorities
Our Brilliant Speaker Faculty Included:
Official Previous Partners
Attending Companies Included:
Explore the Agenda
Dive into cutting-edge LNP innovation across targeting, delivery, CMC and clinical translation through expert-led talks, interactive debates and practical case studies.
Partner With Us
Position your solutions at the forefront of LNP development and connect with biotech and pharma leaders actively advancing next-generation RNA and gene therapies.
Join LNP Leaders
Engage with a highly focused community of LNP experts across discovery, formulation and manufacturing, and build meaningful connections during dedicated networking sessions.